The Epstein-Barr virus (EBV) is one of the most widespread viruses in the world. It is estimated that it is present in the ...

New research unlocks potential treatment for very common virus.

The platform combines a human lymphoid organoid with a microfluidics-based vascularized microenvironment that mimics bone ...

Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and durability of vaccine-induced antibody responses, requiring frequent vaccine updates.

Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and durability of vaccine-induced antibody responses, requiring frequent vaccine updates.

The Epstein-Barr virus (EBV) is one of the world's most common viruses, thought to be lurking in 95 percent of adults. For ...

Long-term humoral immunity relies on long-lived plasma cells in the bone marrow (BM). However, the processes governing plasma ...

Ku explains how many bispecific antibodies can act as molecular bridges, binding a tumor-associated antigen such as ...

ncyte Corp. ( INCY ), a global biopharmaceutical company focused on serious unmet medical needs, announced that MINJUVI (tafasitamab) has been funded in Ontario for the treatment of relapsed or ...

Initial results from RESTORE-PV show DISC-3405 increased hepcidin and lowered serum iron, translating to controlled hematocrit, reduced ...

Initial results from RESTORE-PV show DISC-3405 improves symptoms in polycythemia vera by increasing hepcidin and reducing ...

Cell surface proteins are essential regulators of cell communication, mediating immune activation, cell adhesion, receptor ...